{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:26:59Z","timestamp":1793831219349,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2084099"],"award-info":[{"award-number":["2019R1A2C2084099"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["26-2020-0060"],"award-info":[{"award-number":["26-2020-0060"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have mainly focused more on how diabetes affects the valve than the myocardium in aortic stenosis (AS). In the pressure-overloaded heart, myocardial fibrosis is an important driver of the progression from compensated hypertrophy to heart failure. Using comprehensive noninvasive imaging and plasma proteomics, we investigated whether and how diabetes aggravates the remodeling of the myocardium and its relation with prognosis in AS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Severe AS patients were enrolled in two prospective cohorts for imaging and biomarker analysis. The imaging cohort (n\u2009=\u2009253) underwent echocardiography and cardiac magnetic resonance, and the biomarker cohort (n\u2009=\u2009100) blood sampling with multiplex proximity extension assay for 92 proteomic biomarkers. The composite outcome of hospitalization for heart failure admissions and death was assessed in the imaging cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Diabetic patients were older (70.4\u2009\u00b1\u20096.8 versus 66.7\u2009\u00b1\u200910.1\u00a0years) with more advanced ventricular diastolic dysfunction and increased replacement and diffuse interstitial fibrosis (late gadolinium enhancement % 0.3 [0.0\u20131.6] versus 0.0 [0.0\u20130.5], p\u2009=\u20090.009; extracellular volume fraction %  27.9 [25.7\u201330.1] versus 26.7 [24.9\u201328.5], p\u2009=\u20090.025) in the imaging cohort. Plasma proteomics analysis of the biomarker cohort revealed that 9 proteins (E-selectin, interleukin-1 receptor type 1, interleukin-1 receptor type 2, galectin-4, intercellular adhesion molecule 2, integrin beta-2, galectin-3, growth differentiation factor 15, and cathepsin D) were significantly elevated and that pathways related to inflammatory response and extracellular matrix components were enriched in diabetic AS patients. During follow-up (median 6.3\u00a0years), there were 53 unexpected heart failure admissions or death in the imaging cohort. Diabetes was a significant predictor of heart failure and death, independent of clinical covariates and aortic valve replacement (HR 1.88, 95% CI 1.06\u22123.31, p\u2009=\u20090.030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma proteomic analyses indicate that diabetes potentiates the systemic proinflammatory\u2212profibrotic milieu in AS patients. These systemic biological changes underlie the increase of myocardial fibrosis, diastolic dysfunction, and worse clinical outcomes in severe AS patients with concomitant diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01763-1","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T13:03:32Z","timestamp":1676034212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Systemic proinflammatory\u2212profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome"],"prefix":"10.1186","volume":"22","author":[{"given":"Hyun-Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Soon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Bean","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ji","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"11","key":"1763_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jcmg.2016.10.007","volume":"10","author":"CWL Chin","year":"2017","unstructured":"Chin CWL, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, Jenkins W, Koo M, Mirsadraee S, White AC, et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging. 2017;10(11):1320\u201333.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"1763_CR2","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.jcmg.2020.07.007","volume":"13","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Lee H, Kim SM, Park JB, Kim EK, Chang SA, Park E, Kim HK, Lee W, Kim YJ, et al. Diffuse myocardial fibrosis and diastolic function in aortic stenosis. JACC Cardiovasc Imaging. 2020;13(12):2561\u201372.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"1763_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","volume":"71","author":"TA Treibel","year":"2018","unstructured":"Treibel TA, Kozor R, Schofield R, Benedetti G, Fontana M, Bhuva AN, Sheikh A, Lopez B, Gonzalez A, Manisty C, et al. Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol. 2018;71(8):860\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1763_CR4","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.117.032839","volume":"138","author":"TA Musa","year":"2018","unstructured":"Musa TA, Treibel TA, Vassiliou VS, Captur G, Singh A, Chin C, Dobson LE, Pica S, Loudon M, Malley T, et al. Myocardial scar and mortality in severe aortic stenosis. Circulation. 2018;138(18):1935\u201347.","journal-title":"Circulation"},{"issue":"3","key":"1763_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","volume":"75","author":"RJ Everett","year":"2020","unstructured":"Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A, Bijsterveld P, Tastet L, Musa TA, Dobson L, et al. Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol. 2020;75(3):304\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1763_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jacc.2021.05.047","volume":"78","author":"S Kwak","year":"2021","unstructured":"Kwak S, Everett RJ, Treibel TA, Yang S, Hwang D, Ko T, Williams MC, Bing R, Singh T, Joshi S, et al. Markers of myocardial damage predict mortality in patients with aortic stenosis. J Am Coll Cardiol. 2021;78(6):545\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1763_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1763_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"17","key":"1763_CR9","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","volume":"113","author":"R Katz","year":"2006","unstructured":"Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O\u2019Brien KD. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113(17):2113\u20139.","journal-title":"Circulation"},{"issue":"1","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","volume":"19","author":"M Kopytek","year":"2020","unstructured":"Kopytek M, Zabczyk M, Mazur P, Undas A, Natorska J. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"1763_CR11","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s00125-021-05545-w","volume":"64","author":"M Kopytek","year":"2021","unstructured":"Kopytek M, Mazur P, Zabczyk M, Undas A, Natorska J. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-kappaB and more pronounced valve calcification. Diabetologia. 2021;64(11):2562\u201374.","journal-title":"Diabetologia"},{"issue":"3","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.110.960039","volume":"4","author":"BR Lindman","year":"2011","unstructured":"Lindman BR, Arnold SV, Madrazo JA, Zajarias A, Johnson SN, Perez JE, Mann DL. The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ Heart Fail. 2011;4(3):286\u201392.","journal-title":"Circ Heart Fail"},{"issue":"10","key":"1763_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","volume":"124","author":"I Falcao-Pires","year":"2011","unstructured":"Falcao-Pires I, Hamdani N, Borbely A, Gavina C, Schalkwijk CG, van der Velden J, van Heerebeek L, Stienen GJ, Niessen HW, Leite-Moreira AF, et al. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation. 2011;124(10):1151\u20139.","journal-title":"Circulation"},{"issue":"1","key":"1763_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.hlc.2015.05.019","volume":"25","author":"T Nakamura","year":"2016","unstructured":"Nakamura T, Toda K, Kuratani T, Miyagawa S, Yoshikawa Y, Fukushima S, Saito S, Yoshioka D, Kashiyama N, Daimon T, et al. Diabetes mellitus impairs left ventricular mass regression after surgical or transcatheter aortic valve replacement for severe aortic stenosis. Heart Lung Circ. 2016;25(1):68\u201374.","journal-title":"Heart Lung Circ"},{"issue":"11","key":"1763_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamacardio.2018.3152","volume":"3","author":"P Lancellotti","year":"2018","unstructured":"Lancellotti P, Magne J, Dulgheru R, Clavel MA, Donal E, Vannan MA, Chambers J, Rosenhek R, Habib G, Lloyd G, et al. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3(11):1060\u20138.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"1763_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005417","volume":"10","author":"Y Abramowitz","year":"2017","unstructured":"Abramowitz Y, Vemulapalli S, Chakravarty T, Li Z, Kapadia S, Holmes D, Matsouaka RA, Wang A, Cheng W, Forrester JS, et al. Clinical impact of diabetes mellitus on outcomes after transcatheter aortic valve replacement: insights from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2017;10(11): e005417.","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"1763_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","volume":"30","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372\u201392.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"1763_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.E14.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"1763_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321\u201360.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"1763_CR20","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227.","journal-title":"Circulation"},{"issue":"7","key":"1763_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jcmg.2017.09.005","volume":"11","author":"H Lee","year":"2018","unstructured":"Lee H, Park JB, Yoon YE, Park EA, Kim HK, Lee W, Kim YJ, Cho GY, Sohn DW, Greiser A, et al. Noncontrast myocardial T1 mapping by cardiac magnetic resonance predicts outcome in patients with aortic stenosis. JACC Cardiovasc Imaging. 2018;11(7):974\u201383.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"1763_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4): e95192.","journal-title":"PLoS ONE"},{"issue":"3","key":"1763_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jchf.2019.11.005","volume":"8","author":"J Tromp","year":"2020","unstructured":"Tromp J, Voors AA, Sharma A, Ferreira JP, Ouwerkerk W, Hillege HL, Gomez KA, Dickstein K, Anker SD, Metra M, et al. Distinct pathological pathways in patients with heart failure and diabetes. JACC Heart Fail. 2020;8(3):234\u201342.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1763_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-021-01314-6","volume":"20","author":"L Nesti","year":"2021","unstructured":"Nesti L, Pugliese NR, Sciuto P, De Biase N, Mazzola M, Fabiani I, Trico D, Masi S, Natali A. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1763_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-020-01109-1","volume":"19","author":"L Nesti","year":"2020","unstructured":"Nesti L, Pugliese NR, Sciuto P, Natali A. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach. Cardiovasc Diabetol. 2020;19(1):134.","journal-title":"Cardiovasc Diabetol"},{"key":"1763_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2022.06.049","volume":"363","author":"M Dennis","year":"2022","unstructured":"Dennis M, Howpage S, McGill M, Dutta S, Koay Y, Nguyen-Lal L, Lal S, Wu T, Ugander M, Wang A, et al. Myocardial fibrosis in type 2 diabetes is associated with functional and metabolomic parameters. Int J Cardiol. 2022;363:179\u201384.","journal-title":"Int J Cardiol"},{"key":"1763_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.765071","volume":"8","author":"E Gallinoro","year":"2021","unstructured":"Gallinoro E, Paolisso P, Candreva A, Bermpeis K, Fabbricatore D, Esposito G, Bertolone D, Fernandez Peregrina E, Munhoz D, Mileva N, et al. Microvascular dysfunction in patients with type II diabetes mellitus: invasive assessment of absolute coronary blood flow and microvascular resistance reserve. Front Cardiovasc Med. 2021;8: 765071.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"1763_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","volume":"20","author":"P Paolisso","year":"2021","unstructured":"Paolisso P, Foa A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A, Armillotta M, et al. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021;20(1):33.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1763_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","volume":"35","author":"TC Wong","year":"2014","unstructured":"Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2014;35(10):657\u201364.","journal-title":"Eur Heart J"},{"issue":"10","key":"1763_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.107.727826","volume":"118","author":"RY Kwong","year":"2008","unstructured":"Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118(10):1011\u201320.","journal-title":"Circulation"},{"issue":"7","key":"1763_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.011000","volume":"13","author":"MA Khan","year":"2020","unstructured":"Khan MA, Yang EY, Nguyen DT, Nabi F, Hinojosa J, Jabel M, Nagueh SF, Graviss EA, Shah DJ. Examining the relationship and prognostic implication of diabetic status and extracellular matrix expansion by cardiac magnetic resonance. Circ Cardiovasc Imaging. 2020;13(7): e011000.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"1763_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-019-0836-y","volume":"18","author":"E Ram","year":"2019","unstructured":"Ram E, Kogan A, Levin S, Fisman EZ, Tenenbaum A, Raanani E, Sternik L. Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement. Cardiovasc Diabetol. 2019;18(1):31.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"1763_CR33","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107(7):984\u201391.","journal-title":"Circulation"},{"issue":"2","key":"1763_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1148\/radiol.14141120","volume":"274","author":"SP Lee","year":"2015","unstructured":"Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ, Sohn DW. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology. 2015;274(2):359\u201369.","journal-title":"Radiology"},{"issue":"12","key":"1763_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005594","volume":"10","author":"JB Kim","year":"2017","unstructured":"Kim JB, Kobayashi Y, Moneghetti KJ, Brenner DA, O\u2019Malley R, Schnittger I, Wu JC, Murtagh G, Beshiri A, Fischbein M, et al. GDF-15 (growth differentiation factor 15) is associated with lack of ventricular recovery and mortality after transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10(12): e005594.","journal-title":"Circ Cardiovasc Interv"},{"issue":"17","key":"1763_CR36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/heartjnl-2015-307742","volume":"101","author":"BR Lindman","year":"2015","unstructured":"Lindman BR, Breyley JG, Schilling JD, Vatterott AM, Zajarias A, Maniar HS, Damiano RJ Jr, Moon MR, Lawton JS, Gage BF, et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart. 2015;101(17):1382\u20138.","journal-title":"Heart"},{"issue":"10","key":"1763_CR37","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/ejhf.912","volume":"19","author":"A Sharma","year":"2017","unstructured":"Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O\u2019Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison BA, et al. A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. Eur J Heart Fail. 2017;19(10):1310\u201320.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1763_CR38","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","volume":"96","author":"SJ Hwang","year":"1997","unstructured":"Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96(12):4219\u201325.","journal-title":"Circulation"},{"issue":"9","key":"1763_CR39","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126(9):1260\u201380.","journal-title":"Circ Res"},{"key":"1763_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.vph.2016.02.006","volume":"81","author":"NW van der Hoeven","year":"2016","unstructured":"van der Hoeven NW, Hollander MR, Yildirim C, Jansen MF, Teunissen PF, Horrevoets AJ, van der Pouw Kraan TC, van Royen N. The emerging role of galectins in cardiovascular disease. Vascul Pharmacol. 2016;81:31\u201341.","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"1763_CR41","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.5114\/aoms.2012.28808","volume":"9","author":"J Glogowska-Ligus","year":"2013","unstructured":"Glogowska-Ligus J, Dabek J, Zych-Twardowska E, Tkacz M. Expression analysis of intercellular adhesion molecule-2 (ICAM-2) in the context of classical cardiovascular risk factors in acute coronary syndrome patients. Arch Med Sci. 2013;9(6):1035\u20139.","journal-title":"Arch Med Sci"},{"issue":"3","key":"1763_CR42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/CIRCRESAHA.114.301275","volume":"114","author":"S Israeli-Rosenberg","year":"2014","unstructured":"Israeli-Rosenberg S, Manso AM, Okada H, Ross RS. Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res. 2014;114(3):572\u201386.","journal-title":"Circ Res"},{"issue":"4","key":"1763_CR43","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/ehf2.12728","volume":"7","author":"M Wesseling","year":"2020","unstructured":"Wesseling M, de Poel JHC, de Jager SCA. Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player. ESC Heart Fail. 2020;7(4):1488\u2013501.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"1763_CR44","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/ejhf.1674","volume":"22","author":"MF Hoes","year":"2020","unstructured":"Hoes MF, Tromp J, Ouwerkerk W, Bomer N, Oberdorf-Maass SU, Samani NJ, Ng LL, Lang CC, van der Harst P, Hillege H, et al. The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach. Eur J Heart Fail. 2020;22(11):2102\u201311.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1763_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"1763_CR46","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/dcS15-3015","volume":"39","author":"RM Pollack","year":"2016","unstructured":"Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. 2016;39(Suppl 2):S244-252.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01763-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T05:49:40Z","timestamp":1725601780000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01763-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki, and the cohorts were approved by the institutional review boards of Seoul National University Hospital, Asan Medical Center, and Samsung Medical Center, with all study subjects providing written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}